BIOAGE Labs Inc
BIOA4.390USD
+0.270+6.55%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
157.38MMarket Cap
LossP/E TTM
BIOAGE Labs Inc
4.390
+0.270+6.55%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-10.79%-17.36M
---5.14M
---14.93M
---15.67M
Net income from continuing operations
0.49%-12.93M
---21.13M
---23.41M
---12.99M
Operating gains losses
12.12%37.00K
--47.00K
--38.00K
--33.00K
Other non-cash items
5200.00%53.00K
--0.00
--1.00K
--1.00K
Change in working capital
-60.26%-7.53M
--13.58M
--6.23M
---4.70M
-Change in receivables
---361.00K
----
----
--0.00
-Change in prepaid expenses
-25.93%-1.18M
---761.00K
---23.00K
---937.00K
-Change in other current assets
--1.00K
---240.00K
--25.00K
--0.00
-Change in other current liabilities
---1.09M
--12.50M
---3.31M
--0.00
Cash from non-recurring investing activities
Cash from operating activities
-10.79%-17.36M
---5.14M
---14.93M
---15.67M
Investing cash flow
Net cash from continuing investing activities
--426.00K
--26.00K
--305.00K
--0.00
Capital expenditures
--426.00K
--26.00K
--305.00K
--0.00
Net cash flow from disposal of fixed assets
--426.00K
--26.00K
--305.00K
--0.00
Net cash flow from investment products
---77.56M
----
----
--0.00
Cash from non-current investing activities
Net cash flow from investing activities
---77.99M
---26.00K
---305.00K
--0.00
Financing cash flow
Cash flow from continuous financing activities
-100.89%-1.50M
--24.90M
--190.68M
--168.00M
Net cash flow from debt Issuance/repayment
0.00%-1.50M
---1.50M
---1.50M
---1.50M
Net cash flow from common stock issuance/repurchase
-100.00%0.00
--27.62M
--194.54M
--170.00M
Proceeds from stock option exercised by employees
-100.00%0.00
--25.00K
--184.00K
--3.00K
Net cash flow from other financing activities
100.00%0.00
---1.24M
---2.54M
---502.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
-100.89%-1.50M
--24.90M
--190.68M
--168.00M
Net cash flow
Beginning cash balance
1319.84%354.35M
--334.47M
--159.09M
--24.96M
Current period cash flow changes
-163.58%-96.86M
--19.88M
--175.39M
--152.35M
Effect of exchange rate changes
-163.16%-12.00K
--137.00K
---58.00K
--19.00K
Ending cash balance
45.22%257.49M
--354.35M
--334.47M
--177.31M
Free cash flow
-13.51%-17.79M
---5.16M
---15.24M
---15.67M
Currency unit
USD
USD
USD
USD
Audit opinions
--
--
--
--
